chronic pain

Recent research in Utah highlights cannabis as a potential game-changer in pain management. A study by Management Science Associates (MSA) found a 53% drop in opioid prescriptions among chronic pain patients who used cannabis between 2021 and 2024. The study, presented at a Medical Cannabis Policy...

A new study conducted by a division of Tilray Brands, Inc. (NASDAQ:TLRY) reveals that a substantial majority of medical marijuana patients over the age of 50 are utilizing cannabis to manage chronic pain and arthritis. This research highlights the growing trend among older adults turning to...

This article was originally published on Psychedelic Spotlight and appears here with permission. There is limited research on the combination of psychedelics and opioids. Nonetheless, a study investigating the interaction between opioids and hallucinogens found that low opioid doses tend to...

Members of Congress are set to consider a measure that would streamline research into medical cannabis use for military veterans, reported Marijuana Moment. The Veterans Cannabis Analysis, Research and Effectiveness (CARE) Act was reintroduced last week by Rep. Mariannette Miller-Meeks (R...

Lawmakers in the Lone Star State gave the green light to a measure under which doctors can recommend medical cannabis instead of opioids to patients with chronic pain caused by a myriad of conditions, reported Marijuana Moment. The Texas House Public Health Committee passed the bill from...

Medical cannabis program enrollment jumped by over four times between 2016 and 2020, reaching nearly three million patients in 2020, according to a study published June 14 online in the Annals of Internal Medicine. Researchers, led by Kevin F. Boehnke, Ph.D. from the...

This article was originally published on Cannabis.net and appears here with permission.  Chronic pain is a debilitating condition that affects over 50 million American adults around the country. With 1 in every 5 adults in the United States suffering from chronic pain, it’...

The Centers for Disease Control and Prevention (CDC) proposed new guidelines for prescribing opioid painkillers that encourage doctors to use their best judgment, removing its previous recommended ceilings on doses for chronic pain patients. This is the first comprehensive revision...

Following an unblinded, pre-planned interim analysis by the Independent Data Monitoring Committee (IDMC), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) will stop enrollment in the Phase 3 RALLY study of TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg for fibromyalgia. The...

Project Twenty 21 has published its first findings in the accredited scientific journal Psychopharmacology. The project, poised to provide patients access to affordable medical cannabis treatment, was launched in 2019 at the Royal College of Psychiatrists in London. The UK's national medical...

This article was originally published on Cannabis & Tech Today, and appears here with permission. Chronic back pain is a major issue around the globe. In fact, lower back pain is the leading cause of disability on the planet. The condition affects people from all backgrounds and socio...

The bullish case for Nevro Corp (NYSE: NVRO) — a medical device company that focuses on the treatment of chronic pain — no longer applies for three reasons, according to Morgan Stanley. The Analyst Morgan Stanley's David Lewis downgraded Nevro from Overweight to...

Sometimes, efforts that begin with the best intentions can just end up making things worse. The Centers for Disease Control and state and local regulators have been fighting the national epidemic of prescription opioid painkiller abuse by increasing regulation of prescription opioid drugs and...